Solution Structure of Inhibitor-Free Human Metalloelastase (MMP-12) Indicates an Internal Conformational Adjustment

Journal of Molecular Biology

Volumn 374, Issue 5, 2007, Pages 1333-1344

  Bhaskaran, Rajagopalan ^a   Palmier, Mark O ^a   Bagegni, Nusayba A ^a   Liang, Xiangyang ^a   Van Doren, Steven R ^a  

^a University of Missouri   (United States)

Author keywords

conformational adjustment; crystal structure; macrophage elastase; NMR; solution structure

Indexed keywords

GLYCINE; MACROPHAGE ELASTASE; TRYPTOPHAN;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; BETA SHEET; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME CONFORMATION; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL;

EID: 36248991892     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.10.028     Document Type: Article

References (80)

1. Shapiro S.D. Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth. Thromb. Haemost. 82 (1999) 846-849
2. Matsumoto S., Kobayashi T., Katoh M., Saito S., Ikeda Y., Kobori M., et al. Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development. Am. J. Pathol. 153 (1998) 109-119
3. Liang J., Liu E., Yu Y., Kitajima S., Koike T., Jin Y., et al. Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits. Circulation 113 (2006) 1993-2001
4. Hautamaki R.D., Kobayashi D.K., Senior R.M., and Shapiro S.D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277 (1997) 2002-2004
5. Churg A., Wang R.D., Tai H., Wang X., Xie C., Dai J., et al. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. Am. J. Respir. Crit. Care Med. 167 (2003) 1083-1089
6. Johnson J.L., George S.J., Newby A.C., and Jackson C.L. Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc. Natl Acad. Sci. USA 102 (2005) 15575-15580
7. Curci J.A., Liao S., Huffman M.D., Shapiro S.D., and Thompson R.W. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J. Clin. Invest. 102 (1998) 1900-1910
8. Freestone T., Turner R.J., Coady A., Higman D.J., Greenhalgh R.M., and Powell J.T. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1145-1151
9. Vaalamo M., Karjalainen-Lindsberg M.L., Puolakkainen P., Kere J., and Saarialho-Kere U. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am. J. Pathol. 152 (1998) 1005-1014
10. Wang X., Liang J., Koike T., Sun H., Ichikawa T., Kitajima S., et al. Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits. Am. J. Pathol. 165 (2004) 1375-1383
11. Liu M., Sun H., Wang X., Koike T., Mishima H., Ikeda K., et al. Association of increased expression of macrophage elastase (matrix metalloproteinase 12) with rheumatoid arthritis. Arthritis Rheum. 50 (2004) 3112-3117
12. Overall C.M., and Kleifeld O. Tumour microenvironment-opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev. Cancer 6 (2006) 227-239
13. Johnson J.L. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Expert. Rev. Cardiovasc. Ther. 5 (2007) 265-282
14. Bertini I., Calderone V., Fragai M., Giachetti A., Loconte M., Luchinat C., et al. Exploring the subtleties of drug-receptor interactions: the case of matrix metalloproteinases. J. Am. Chem. Soc. (2007)
15. Devel L., Rogakos V., David A., Makaritis A., Beau F., Cuniasse P., et al. Development of selective inhibitors and substrate of matrix metalloproteinase-12. J. Biol. Chem. 281 (2006) 11152-11160
16. Dublanchet A.C., Ducrot P., Andrianjara C., O'Gara M., Morales R., Compere D., et al. Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors. Bioorg. Med. Chem. Lett. 15 (2005) 3787-3790
17. Morales R., Perrier S., Florent J.M., Beltra J., Dufour S., De Mendez I., et al. Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12. J. Mol. Biol. 341 (2004) 1063-1076
18. Shipley J.M., Wesselschmidt R.L., Kobayashi D.K., Ley T.J., and Shapiro S.D. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc. Natl Acad. Sci. USA 93 (1996) 3942-3946
19. Chandler S., Cossins J., Lury J., and Wells G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem. Biophys. Res. Commun. 228 (1996) 421-429
20. Gronski Jr. T.J., Martin R.L., Kobayashi D.K., Walsh B.C., Holman M.C., Huber M., et al. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J. Biol. Chem. 272 (1997) 12189-12194
21. Shapiro S.D., Kobayashi D.K., and Ley T.J. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268 (1993) 23824-23829
22. Shapiro S.D. Animal models for chronic obstructive pulmonary disease: age of klotho and marlboro mice. Am. J. Respir. Cell Mol. Biol. 22 (2000) 4-7
23. Weiss S.J. Tissue destruction by neutrophils. N. Engl. J. Med. 320 (1989) 365-376
24. Banda M.J., Rice A.G., Griffin G.L., and Senior R.M. Alpha 1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase. J. Biol. Chem. 263 (1988) 4481-4484
25. Liu Z., Zhou X., Shapiro S.D., Shipley J.M., Twining S.S., Diaz L.A., et al. The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 102 (2000) 647-655
26. Okada Y., Watanabe S., Nakanishi I., Kishi J., Hayakawa T., Watorek W., et al. Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett. 229 (1988) 157-160
27. Itoh Y., and Nagase H. Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J. Biol. Chem. 270 (1995) 16518-16521
28. Shapiro S.D., Griffin G.L., Gilbert D.J., Jenkins N.A., Copeland N.G., Welgus H.G., et al. Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J. Biol. Chem. 267 (1992) 4664-4671
29. Shipley J.M., Doyle G.A., Fliszar C.J., Ye Q.Z., Johnson L.L., Shapiro S.D., et al. The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J. Biol. Chem. 271 (1996) 4335-4341
30. Jensen S.A., Andersen P., Vrhovski B., and Weiss A.S. Rational design of tropoelastin peptide-based inhibitors of metalloproteinases. Arch. Biochem. Biophys. 409 (2003) 335-340
31. Lang R., Kocourek A., Braun M., Tschesche H., Huber R., Bode W., and Maskos K. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure. J. Mol. Biol. 312 (2001) 731-742
32. Nar H., Werle K., Bauer M.M., Dollinger H., and Jung B. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor. J. Mol. Biol. 312 (2001) 743-751
33. Lovejoy B., Welch A.R., Carr S., Luong C., Broka C., Hendricks R.T., et al. Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors. Nat. Struct. Biol. 6 (1999) 217-221
34. Sires U.I., Murphy G., Baragi V.M., Fliszar C.J., Welgus H.G., and Senior R.M. Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin. Biochem. Biophys. Res. Commun. 204 (1994) 613-620
35. Bertini I., Calderone V., Cosenza M., Fragai M., Lee Y.M., Luchinat C., et al. Conformational variability of matrix metalloproteinases: beyond a single 3D structure. Proc. Natl Acad. Sci. USA 102 (2005) 5334-5339
36. Maskos K. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors. Biochimie 87 (2005) 249-263
37. Moy F.J., Chanda P.K., Cosmi S., Pisano M.R., Urbano C., Wilhelm J., and Powers R. High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR. Biochemistry 37 (1998) 1495-1504
38. Lovejoy B., Hassell A.M., Luther M.A., Weigl D., and Jordan S.R. Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself. Biochemistry 33 (1994) 8207-8217
39. Chen L., Rydel T.J., Gu F., Dunaway C.M., Pikul S., Dunham K.M., and Barnett B.L. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes. J. Mol. Biol. 293 (1999) 545-557
40. Bertini I., Calderone V., Fragai M., Luchinat C., Maletta M., and Yeo K.J. Snapshots of the reaction mechanism of matrix metalloproteinases. Angew. Chem. Int. Ed. Engl. 45 (2006) 7952-7955
41. Moy F.J., Chanda P.K., Chen J.M., Cosmi S., Edris W., Skotnicki J.S., et al. NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound. Biochemistry 38 (1999) 7085-7096
42. Bhaskaran R., and Van Doren S.R. (1)H, (13)C, and (15)N peak assignments and secondary structure of human macrophage metalloelastase (MMP-12) in its inhibitor-free state. J. Biomol. NMR 36 (2006) 55
43. 15N assignments of MMP-12, a key protease implicated in lung tissue remodeling. J. Biomol. NMR 31 (2005) 260
44. Crabbe T., Zucker S., Cockett M.I., Willenbrock F., Tickle S., O'Connell J.P., et al. Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1. Biochemistry 33 (1994) 6684-6690
45. Windsor L.J., Bodden M.K., Birkedal-Hansen B., Engler J.A., and Birkedal-Hansen H. Mutational analysis of residues in and around the active site of human fibroblast-type collagenase. J. Biol. Chem. 269 (1994) 26201-26207
46. Steele D.L., El-Kabbani O., Dunten P., Windsor L.J., Kammlott R.U., Crowther R.L., et al. Expression, characterization and structure determination of an active site mutant (Glu202-Gln) of mini-stromelysin-1. Protein Eng. 13 (2000) 397-405
47. Cha J., and Auld D.S. Site-directed mutagenesis of the active site glutamate in human matrilysin: investigation of its role in catalysis. Biochemistry 36 (1997) 16019-16024
48. Mannino C., Nievo M., Machetti F., Papakyriakou A., Calderone V., Fragai M., and Guarna A. Synthesis of bicyclic molecular scaffolds (BTAa): an investigation towards new selective MMP-12 inhibitors. Bioorg. Med. Chem. 14 (2006) 7392-7403
49. Cornilescu G., Ramirez B.E., Frank M.K., Clore G.M., Gronenborn A.M., and Bax A. Correlation between (3h)J(NC′) and hydrogen bond length in proteins. J. Am. Chem. Soc. 121 (1999) 6275-6279
50. Eisenberg D., Luthy R., and Bowie J.U. VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol. 277 (1997) 396-404
51. Sippl M.J. Recognition of errors in three-dimensional structures of proteins. Proteins: Struct. Funct. Genet. 17 (1993) 355-362
52. Davis I.W., Leaver-Fay A., Chen V.B., Block J.N., Kapral G.J., Wang X., et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. (2007)
53. Laskowski R.A., Rullmannn J.A., MacArthur M.W., Kaptein R., and Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8 (1996) 477-486
54. Aurora R., and Rose G.D. Helix capping. Protein Sci. 7 (1998) 21-38
55. Starich M.R., Sandman K., Reeve J.N., and Summers M.F. NMR structure of HMfB from the hyperthermophile, Methanothermus fervidus, confirms that this archaeal protein is a histone. J. Mol. Biol. 255 (1996) 187-203
56. Kuszewski J., Gronenborn A.M., and Clore G.M. Improving the packing and accuracy of NMR structures with a pseudopotential for the radius of gyration. J. Am. Chem. Soc. 121 (1999) 2337-2338
57. Chothia C., and Lesk A.M. Helix movements in proteins. Trends Biochem. Sci. 10 (1985) 116-118
58. Frauenfelder H., Sligar S.G., and Wolynes P.G. The energy landscapes and motions of proteins. Science 254 (1991) 1598-1603
59. Hilser V.J., Dowdy D., Oas T.G., and Freire E. The structural distribution of cooperative interactions in proteins: analysis of the native state ensemble. Proc. Natl Acad. Sci. USA 95 (1998) 9903-9908
60. Pan H., Lee J.C., and Hilser V.J. Binding sites in Escherichia coli dihydrofolate reductase communicate by modulating the conformational ensemble. Proc. Natl Acad. Sci. USA 97 (2000) 12020-12025
61. Eisenmesser E.Z., Millet O., Labeikovsky W., Korzhnev D.M., Wolf-Watz M., Bosco D.A., et al. Intrinsic dynamics of an enzyme underlies catalysis. Nature 438 (2005) 117-121
62. Boehr D.D., McElheny D., Dyson H.J., and Wright P.E. The dynamic energy landscape of dihydrofolate reductase catalysis. Science 313 (2006) 1638-1642
63. Liu T., Whitten S.T., and Hilser V.J. Functional residues serve a dominant role in mediating the cooperativity of the protein ensemble. Proc. Natl Acad. Sci. USA 104 (2007) 4347-4352
64. Moy F.J., Pisano M.R., Chanda P.K., Urbano C., Killar L.M., Sung M.L., and Powers R. Assignments, secondary structure and dynamics of the inhibitor-free catalytic fragment of human fibroblast collagenase. J. Biomol. NMR 10 (1997) 9-19
65. Binkowski T.A., Naghibzadeh S., and Liang J. CASTp: Computed Atlas of Surface Topography of proteins. Nucleic Acids Res. 31 (2003) 3352-3355
66. Van Doren S.R., Kurochkin A.V., Ye Q.Z., Johnson L.L., Hupe D.L., and Zuiderweg E.R.P. Assignments for the main-chain nuclear magnetic resonances and delineation of the secondary structure of the catalytic domain of human stromelysin-1 as obtained from triple-resonance 3D NMR experiments. Biochemistry 32 (1993) 13109-13122
67. Arumugam S., Hemme C.L., Yoshida N., Suzuki K., Nagase H., Berjanskii M., et al. TIMP-1 contact sites and perturbations of stromelysin 1 mapped by NMR and a paramagnetic surface probe. Biochemistry 37 (1998) 9650-9657
68. Lichtarge O., Bourne H.R., and Cohen F.E. An evolutionary trace method defines binding surfaces common to protein families. J. Mol. Biol. 257 (1996) 342-358
69. Lichtarge O., Bourne H.R., and Cohen F.E. Evolutionarily conserved Galphabetagamma binding surfaces support a model of the G protein-receptor complex. Proc. Natl Acad. Sci. USA 93 (1996) 7507-7511
70. Lichtarge O., Yamamoto K.R., and Cohen F.E. Identification of functional surfaces of the zinc binding domains of intracellular receptors. J. Mol. Biol. 274 (1997) 325-337
71. Lichtarge O., and Sowa M.E. Evolutionary predictions of binding surfaces and interactions. Curr. Opin. Struct. Biol. 12 (2002) 21-27
72. Madabushi S., Gross A.K., Philippi A., Meng E.C., Wensel T.G., and Lichtarge O. Evolutionary trace of G protein-coupled receptors reveals clusters of residues that determine global and class-specific functions. J. Biol. Chem. 279 (2004) 8126-8132
73. Garimella R., Liu X., Qiao W., Liang X., Zuiderweg E.R., Riley M.I., and Van Doren S.R. Hsc70 contacts helix III of the J domain from polyomavirus T antigens: addressing a dilemma in the chaperone hypothesis of how they release E2F from pRb. Biochemistry 45 (2006) 6917-6929
74. Suel G.M., Lockless S.W., Wall M.A., and Ranganathan R. Evolutionarily conserved networks of residues mediate allosteric communication in proteins. Nat. Struct. Biol. 10 (2003) 59-69
75. Lockless S.W., and Ranganathan R. Evolutionarily conserved pathways of energetic connectivity in protein families. Science 286 (1999) 295-299
76. Mihalek I., Res I., and Lichtarge O. A family of evolution-entropy hybrid methods for ranking protein residues by importance. J. Mol. Biol. 336 (2004) 1265-1282
77. Mihalek I., Res I., and Lichtarge O. Evolutionary trace report_maker: a new type of service for comparative analysis of proteins. Bioinformatics 22 (2006) 1656-1657
78. Fischer M.W., Zeng L., Majumdar A., and Zuiderweg E.R. Characterizing semilocal motions in proteins by NMR relaxation studies. Proc. Natl Acad. Sci. USA 95 (1998) 8016-8019
79. Parkar A.A., Stow M.D., Smith K., Panicker A.K., Guilloteau J.P., Jupp R., and Crowe S.J. Large-scale expression, refolding, and purification of the catalytic domain of human macrophage metalloelastase (MMP-12) in Escherichia coli. Protein Expression Purif. 20 (2000) 152-161
80. Koradi R., Billeter M., and Wüthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics 14 (1996) 51-55